EGFR and central nervous system cancer: Meta-analyses of studies on gliomas (including all grades) have proposed that the expression of the EGFR protein [10] and mutations in PTEN [83] may have negative effects on overall survival, although their effects have not been evaluated individually in IDH1-W-GBs.